ArticleDermatology and therapy2023

Real-World, Retrospective, Multicenter, Observational Study on the Use of the First Liquid AbobotulinumtoxinA in Italy.

Carlo Di Gregorio et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.